Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.24.1.1.u2
Stockholders’ Equity (Tables)
 9 Months Ended
Apr. 30, 2024
Stockholders’ Equity [Abstract]  
Schedule of Share-based Compensation Expense The amounts of share-based compensation expense recognized in the periods presented are as follows:
    Three months ended
April 30,		     Nine months ended
April 30,		  
    2024     2023     2024     2023  
Stock options and performance stock units   $ 90     $ 211     $ 833     $ 622  
Restricted stock units     117       277       710       666  
    $ 207     $ 488     $ 1,543     $ 1,288  
The following table sets forth the amount of expense related to share-based payment arrangements included in specific line items in the accompanying statements of operations:
    Three months ended
April 30,		     Nine months ended
April 30,		  
    2024     2023     2024     2023  
Selling, general and administrative   $ 199     $ 482     $ 1,518     $ 1,271  
Cost of revenues     8       6       25       17  
    $ 207     $ 488     $ 1,543     $ 1,288  
Schedule of Stock Option Activity The following table summarizes stock option activity during the nine month period ended April 30, 2024:
    Options     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term		   Aggregate
Intrinsic
Value
(000s)		  
Outstanding at July 31, 2023     3,829,500     $ 2.61          
             —
  
Granted     125,000       1.38            
Exercised    
—
      
—
         $  
Cancelled or expired     (2,122,630 )   $ 1.61            
Outstanding at end of period     1,831,870     $ 2.37     2.1 years   $ —  
Exercisable at end of period     1,215,203     $ 2.49     1.8 years   $ —  
Schedule of Restricted Stock Unit (“RSU”) Activity The following table summarizes RSU activity for the nine months ended April 30, 2024:
    Number of
RSUs
outstanding		     Weighted
Average Fair
Value per
Unit at
Date of
Grant		     Weighted
Average
Remaining
Contractual
Term		     Aggregate
Intrinsic
Value
(000s)		  
Outstanding at beginning of fiscal year     557,490     $ 2.21       1.1 years       825  
Granted     405,825     $ 1.31              
             —
  
Vested     (475,222 )   $ 2.24                  
Cancelled     (100,000 )   $ 1.97                  
Outstanding at end of period     388,093     $ 1.31       1.5 years     $ 404  
Expected to vest at end of period     388,093     $ 1.31       1.5 years     $ 404